SEC Filing Summary: Amedica Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Amedica Corporation on August 7, 2014. The filing serves to announce the financial results for the second quarter of fiscal year 2014. The registrant is incorporated in Delaware with principal executive offices in Salt Lake City, Utah.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the body of this 8-K document.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It solely references the issuance of a press release containing the second-quarter results.
Guidance, Outlook, and Risks
The document does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. The report explicitly states that the information contained in the attached press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 7, 2014) for actual Q2 2014 financial figures.
- Verify the discrepancy between the request metadata (Sintx Technologies, Inc.) and the filing registrant (Amedica Corporation).
- Confirm the specific revenue and net income figures for the second quarter of fiscal 2014 from the attached press release.
- Check for any subsequent filings that may provide updated liquidity or debt positions.